The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

OD6 Metals rediscovers ultra high-grade Big Jim fluorspar lode

OD6 Metals has rediscovered the historically significant high-grade Big Jim fluorspar lode at its Quinn project…
The Market Online Video

The ASX Today: Aussie market caught between Wall Street records, unstoppable oil – and all on Budget Day

Hello and welcome to HotCopper’s The ASX Today, I’m Seja Al Zaidi.
HotCopper Daily Market Trends Graphic

Tuesday’s HotCopper trends: Elevtra, Metallium, EV Resources, and other daily topics

the S&P/ASX 200 is lower today, dropping 35.20 points or 0.40% to 8,666.60. Bottom performing stocks…

Hazer Group signs MoU to assess Australian energy independence

Hazer Group has entered into a non-binding MoU to assess opportunities for developing low carbon liquid…